{
  "trial_id": "NCT02717949",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Willing and able to provide written informed consent",
      "label": "met"
    },
    {
      "criterion": "Male or female >18 years of age",
      "label": "met"
    },
    {
      "criterion": "Serum HCV RNA levels of >1,000 IU per milliliter or higher",
      "label": "unknown"
    },
    {
      "criterion": "HCV treatment experienced or na\u00efve",
      "label": "met"
    },
    {
      "criterion": "Chronic Hepatitis C based on the judgment of the investigator",
      "label": "met"
    },
    {
      "criterion": "HCV genotype 1, 2, 3, 4",
      "label": "unknown"
    },
    {
      "criterion": "Indolent Non-Hodgkin's lymphoma",
      "label": "unknown"
    },
    {
      "criterion": "Karnofsky performance status > 70%",
      "label": "met"
    },
    {
      "criterion": "Creatinine clearance \u226560 mL/min",
      "label": "unknown"
    },
    {
      "criterion": "Hg >12 g/dL for male",
      "label": "unknown"
    },
    {
      "criterion": "All women of child-bearing potential who take ribavirin will need to have a negative urine pregnancy test",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Life expectancy < 6 months",
      "label": "not_met"
    },
    {
      "criterion": "Co-infection with hepatitis B",
      "label": "unknown"
    },
    {
      "criterion": "Prior chemotherapy for lymphoma",
      "label": "not_met"
    },
    {
      "criterion": "Decompensated liver disease in which pegylated interferon is contraindicated.",
      "label": "not_met"
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "7",
    "trial_id": "NCT02717949",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}